Preferred Label : Aromatase deficiency;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Pseudohermaphroditism, female, due to placental aromatase deficiency;
Description : Aromatase deficiency is a rare autosomal recessive disorder in which individuals cannot
synthesize endogenous estrogens. If a fetus lacks aromatase activity, dehydroepiandrosterone
sulfate produced by the fetal adrenal glands cannot be converted to estrogen by the
placenta, and is converted to testosterone peripherally and results in virilization
of both fetus and mother. Virilization manifests as pseudohermaphroditism in female
infants, with hirsutism and acne in the mother; the maternal indicators resolve following
delivery. Affected females are usually diagnosed at birth because of the pseudohermaphroditism.
Cystic ovaries and delayed bone maturation can occur during childhood and adolescence
in these girls, who present at puberty with primary amenorrhea, failure of breast
development, virilization, and hypergonadotropic hypogonadism. Affected males do not
present with obvious defects at birth. Their clinical symptoms include tall stature,
delayed skeletal maturation, delayed epiphyseal closure, bone pain, eunuchoid body
proportions, and excess adiposity. Estrogen replacement therapy reverses the symptoms
in males and females (summary by Jones et al., 2007).;
Prefixed ID : #613546;
Origin ID : 613546;
UMLS CUI : C1960539;
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)